ASEM documentary overview
Official National Advisory Committee on Immunization document (2022) on “Archived 33: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine [2022-02-17]”. NACI recommendations for use of the recombinant protein subunit COVID-19 vaccine Novavax Nuvaxovid: Methods, epidemiology, vaccine characteristics, clinical data, administration, safety, adverse events and more.
This overview helps you identify the document. Always consult the current official publication for clinical recommendations.
Official document